Home › Ovarian Cancer › Illinois › Springfield
Ovarian Cancer clinical trials in Springfield, IL
4 studies for Ovarian Cancer are looking for participants at sites in and around Springfield (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Recruiting
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- Southern Illinois University - Simmons Cancer Institute, Springfield
- Springfield Clinic Radiology - 800 Building, Springfield
- Springfield Clinic Urgent Care Plus, Springfield
- and 4 more
About Ovarian Cancer
Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.
More about Ovarian Cancer on MedlinePlus
Ovarian Cancer trials in other cities
- Houston, TX89 studies
- New York City, NY69 studies
- Boston, MA61 studies
- Los Angeles, CA50 studies
- Nashville, TN49 studies
- Arlington, VA46 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO38 studies
- Chicago, IL36 studies
- San Antonio, TX31 studies
- Cleveland, OH30 studies
Other studies in Springfield
- Non-Small Cell Lung Cancer13 studies
- Lung Cancer12 studies
- Colorectal Cancer9 studies
- Acute Myeloid Leukemia8 studies
- Breast Cancer8 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Kidney Cancer (Renal Cell Carcinoma)6 studies
- Prostate Cancer6 studies
- Cancer (all types)6 studies
- Bladder Cancer6 studies
- Pancreatic Cancer5 studies
- Melanoma5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.